Cost-Effectiveness of Ibrutinib as First-line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- October 6, 2023
published in
- Value in health regional issues Journal